N
OSCR icon

Natixis’s Oscar Health OSCR Stock Holding History

Natixis’s Portfolio OSCR Stock Details OSCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-51,900
Closed -$746K – 1267
2025
Q4 		$746K Buy
+51,900
New +$898K ﹤0.01% 773

Other funds holding OSCR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
TCMNY
Thrive Capital Management (New York) New York $3.81B AUM 45.58% 1-Year Est. Return
BC
BIT Capital Berlin, Germany $3.38B AUM 214.12% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Natixis's OSCR Position: Q1 2026 in Review

Natixis sold out of Oscar Health (OSCR) in Q1 2026, closing a stake of 51,900 shares — an estimated $746K sold.

Natixis first reported a position in OSCR in Q4 2025 and held it in 1 quarter. The position peaked at $746K in Q4 2025. 333 funds tracked by Wall St. Rank hold OSCR as of Q1 2026.

  • Natixis reported no remaining Oscar Health position as of Q1 2026 after selling out during the quarter.
  • Natixis sold 51,900 Oscar Health shares in Q1 2026, an estimated $746K.
  • Natixis first reported a position in Oscar Health in Q4 2025 and held it in 1 quarter.
  • Natixis's Oscar Health position peaked at $746K in Q4 2025.
  • 333 funds tracked by Wall St. Rank held Oscar Health as of Q1 2026.

Based on Natixis's 13F filing for Q1 2026, filed 14 May 2026.